Paul J. Mellett
2014
In 2014, Paul J. Mellett earned a total compensation of $1.3M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
| Bonus | $117,891 |
|---|---|
| Option Awards | $877,954 |
| Salary | $322,408 |
| Other | $11,369 |
| Total | $1,329,622 |
Mellett received $878K in option awards, accounting for 66% of the total pay in 2014.
Mellett also received $117.9K in bonus, $322.4K in salary and $11.4K in other compensation.
Rankings
In 2014, Paul J. Mellett's compensation ranked 6,307th out of 13,032 executives tracked by ExecPay. In other words, Mellett earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,307 out of 13,032 | 52nd |
Division Manufacturing | 2,297 out of 4,966 | 54th |
Major group Chemicals And Allied Products | 772 out of 1,686 | 54th |
Industry group Drugs | 605 out of 1,365 | 56th |
Industry Pharmaceutical Preparations | 462 out of 1,043 | 56th |
Source: SEC filing on January 13, 2016.
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2014.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019